Long term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty

Cornea

Volumn 28, Issue 6, 2009, Pages 715-716

  Birnbaum, Florian ^a   Reis, Alexander ^a   Reinhard, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

CORNEA RODENT ULCER; CORNEA TRANSPLANTATION; DRUG EFFICACY; DRUG TOLERABILITY; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; KERATITIS; KERATOCONJUNCTIVITIS; LETTER; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PUNCTATE KERATITIS;

ADMINISTRATION, TOPICAL; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; OINTMENTS; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STEROIDS; TACROLIMUS;

EID: 67650587419     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318199fa8c     Document Type: Letter

References (5)

1. Dhaliwal JS, Mason BF, Kaufman SC. Long term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty. Cornea. 2008;27:488-93.
2. Mayer K, Reinhard T, Reis A, et al. FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients [in German]. Klin Monatsbl Augenheilkd. 2001; 218:733-736.
3. Reinhard T, Reis A, Mayweg S, et al. Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study [in German]. Klin Monatsbl Augenheilkd. 2002;219:125-131.
4. Reinhard T, Mayweg S, Reis A, et al. Topical FK506 as immunoprophylaxis after allogeneic penetratingnormal-risk keratoplasty:arandomized clinical pilot study. Transpl Int. 2005;18: 193-197.
5. Reis A, Mayweg S, Birnbaum F, et al. Long-term results of FK 506 eye drops following corneal transplantation [in German]. Klin Monatsbl Augenheilkd. 2008;225:57-61.